Rheumatology International

Indexed by Medline, Scopus, Embase, Science Citation Index Expanded,Journal Impact Factor 2.9 (2024; Q2 in Rheumatology), CiteScore 7 (2024; Q1 in Rheumatology)

[Rheumatology International @Rheumatol_Int]

🎉 Congratulations to the Rheumatology International editorial team!
🏅 Recognised by Springer Nature for editorial excellence, based on outstanding author feedback.
Your passion and commitment shape the future of rheumatology publishing. https://t.co/dDkrP64hJC

[Rheumatology International @Rheumatol_Int]

All rheumatology and allied health specialists are invited to submit their original research, surveys, and reviews for a new thematic collection on Artificial Intelligence.
👉https://t.co/vqXZ0Q2BcI
All submissions are subject to rigorous peer review.

[Rheumatology International @Rheumatol_Int]

Glucocorticoid-induced #diabetes remains an often overlooked issue in rheumatology.
👉https://t.co/OE9QMWaNWp
This review provides a comprehensive look at its mechanisms, risk factors, and relevance for everyday clinical care.

[Rheumatology International @Rheumatol_Int]

🧩Understanding “Psout” — when #PsA meets #gout
👉https://t.co/V78NegloRg
✅Shared pathophysiology: uric acid–driven inflammation via IL-23/IL-17 axis
✅“Psout” = more peripheral, destructive, and treatment-resistant phenotype
✅Early recognition essential

[Rheumatology International @Rheumatol_Int]

🦋#Lupus arthritis-ultrasound insights
https://t.co/0CHCx40ooE
📊In a large #SLE cohort:
🤲Wrists & 🦵knees = most commonly inflamed joints+often cluster together
🔬Low-grade synovitis frequent - highlighting the value of US to detect subclinical inflammation beyond clinical exam

[Rheumatology International @Rheumatol_Int]

On #WorldArthritisDay,
Rheumatology International reaffirms its mission to connect global research and clinical excellence.
We publish high-quality evidence that advances understanding and improves patient care.
🔗 Read the latest evidence: https://t.co/lSVY6NOYJp

[Rheumatology International @Rheumatol_Int]

🧩 #ASIAsyndrome — rare but increasingly seen after #implants or #fillers.
Think ASIA when unexplained autoimmune symptoms follow adjuvant exposure.
Ultrasound can aid diagnosis!!
👉https://t.co/pzNXLWLMUk

[Rheumatology International @Rheumatol_Int]

Inflammatory arthritis affects work
In POLNOR-Rheuma cohort (n=1,060),patients with RA,PsA,axSpA had similar work impairment (25-28%) but RA/PsA showed greater limitations
✅High disease activity=worse productivity
✅Annual indirect costs €1.21 billion
https://t.co/Rru9eWiy28

[Rheumatology International @Rheumatol_Int]

Depicting gouty arthritis at the Royal Court of Spain: the case of Pablo de Valladolid (1587–1648), the jester of King Philip IV
👉https://t.co/qdeaWd0UTH

[Rheumatology International @Rheumatol_Int]

🧬 Patients with Sjögren’s disease have a >15× higher risk of lymphoma vs the general population.
🔹 Cryoglobulinemia = strongest predictor
🔹 >50% of deaths in SjD+lymphoma due to the malignancy
Large Spanish prospective cohort study
👉https://t.co/EEUYuWRjdd

[Rheumatology International @Rheumatol_Int]

End-stage kidney disease in #lupus — new insights from https://t.co/ZGcCYay99t
Among 2837 SLE patients, 7.4%➡️ESKD
⚠️Higher risk in men (HR 3.37) and Māori/Pacific (HR≈4.6).
💔Māori patients had poorer survival (HR 2.17).
Action needed to ⬇️disparities & improve outcomes

[Rheumatology International @Rheumatol_Int]

Early vs.delayed #lupusNephritis
by @KaWegiel68670 et al. https://t.co/bjcg8wyTnn
Delayed-onset LN-сlose monitoring is key:
➡️more severe disease
➡️higher prevalence of anti-dsDNA,anti-Sm,anti-Ro, anti-RNP
➡️greater need for intensive immunosuppression
➡️class IV most common

[Rheumatology International @Rheumatol_Int]

🌿#Lifestyle matters in #lupus! A systematic review of 102 studies by @IoannisParodis et al.
https://t.co/SL8PmrXSMZ
💪Exercise⬇️fatigue & boosts mood
🧠Psychological support improves anxiety & quality of life
🥗Mediterranean & low-fat diets⬇️CV risk
☀️UV protection is essential

[Rheumatology International @Rheumatol_Int]

Tongue necrosis=Think GCA!
👉https://t.co/OJp1FaCfNo
✅Rare (2–4%) but can be first sign of #GCA (in ~33% cases)
✅50 y/o + lingual ischemia?🔎Rule out GCA
✅High risk of vision loss & tissue damage if missed
✅Tx: GC, add TCZ if relapse/refractory

[Rheumatology International @Rheumatol_Int]

🆕by @RheumKrakow
👉https://t.co/3CZ5wamARY
🔹In #SLE VCAM-1 levels↑vs controls
➡️but no difference between active & inactive disease
📌Still, VCAM-1 correlated with disease activity
🔹PECAM-1 & ICAM-1→limited diagnostic utility
📈though PECAM-1 linked with disease duration

[Rheumatology International @Rheumatol_Int]

🧬 VEXAS syndrome: a challenging autoinflammatory disorder caused by somatic UBA1 mutations
– Multisystem inflammation
– Cytopenias
– Steroid-sparing response to IL-1 & IL-6 inhibitors
🧪Early genetic testing is key
🧠Curative option: HSCT(limited by age)
https://t.co/PtkPUEeObT

[Rheumatology International @Rheumatol_Int]

How do rheumatologists screen for #RA-#ILD?
A national survey shows wide variation
✅Chest CT (77.6%), X-ray (72.9%), PFTs (65.4%)
📌Many screen only if symptoms present
📉 Limited DLCO access & MDT support in some settings➡️ Standardized approaches needed
https://t.co/1psi4EaJAe

[Rheumatology International @Rheumatol_Int]

🤖Can #ChatGPT help diagnose rheumatic diseases?
✅ChatGPT-4 listed correct diagnosis among top 3 in 60% of cases vs. 55% for rheumatologists
✅For confirmed IRD cases, it reached 86% accuracy in top 3 (vs. 74%)
🔍AI may assist in early detection & triage
https://t.co/6ETegGH8Y2

[Rheumatology International @Rheumatol_Int]

This new review by Dr. Kamil Koszela et al. highlights the role of spinal #mesotherapy in chronic back pain syndrome:
📚 800+ patients across 9 studies
✅ Effective to reduce pain, restore mobility & enhance quality of life
❌ No serious adverse events
👉https://t.co/hix4naZixT

[Rheumatology International @Rheumatol_Int]

🧪 New study: Uric acid & inflammation in older adults
📈 Untreated hyperuricemia = ↑ IL-6 & IL-1β
📉 Proper treatment = ↓ IL-1β
💡 Uric acid control may help modulate inflammation
🧬 More research needed — but clinical impact is clear!
https://t.co/Bw1XVHB51f

[Rheumatology International @Rheumatol_Int]

🔥Highly cited in Rheumatology International!
How well does #AI advise patients on 💊methotrexate?
This study compares ChatGPT, BARD & Bing.
📊 GPT-4: 100% accurate and complete
⚠️ BARD & Bing: errors and hallucinations
📖 Read the full text: https://t.co/qEsFrADfPS